APA (7th ed.) Citation

Y, Y., L, Z., Z, Y., Y, H., M, C., S, Z., . . . B, Z. (2026). Efficacy and safety of neoadjuvant chemotherapy with immunotherapy versus chemotherapy alone in esophageal squamous cell carcinoma: A meta-analysis based on randomized controlled trials. Frontiers in immunology, 17, 1825905. https://doi.org/10.3389/fimmu.2026.1825905

Chicago Style (17th ed.) Citation

Y, Ye, Zhang L, Yang Z, Huang Y, Chen M, Zhang S, Zeng T, Chen C, and Zheng B. "Efficacy and Safety of Neoadjuvant Chemotherapy with Immunotherapy Versus Chemotherapy Alone in Esophageal Squamous Cell Carcinoma: A Meta-analysis Based on Randomized Controlled Trials." Frontiers in Immunology 17 (2026): 1825905. https://doi.org/10.3389/fimmu.2026.1825905.

MLA (9th ed.) Citation

Y, Ye, et al. "Efficacy and Safety of Neoadjuvant Chemotherapy with Immunotherapy Versus Chemotherapy Alone in Esophageal Squamous Cell Carcinoma: A Meta-analysis Based on Randomized Controlled Trials." Frontiers in Immunology, vol. 17, 2026, p. 1825905, https://doi.org/10.3389/fimmu.2026.1825905.